Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-associated antigen GM2 is a membrane glycolipid highly expressed across several aggressive cancers but minimally present on healthy tissue. It plays critical roles in promoting tumor progression through enhanced migration/invasion capabilities, angiogenesis induction, immune evasion mechanisms, and modulation of key signaling pathways. Targeted immunotherapies—including monoclonal antibodies and CAR-T technologies—are under investigation due to the favorable expression profile and functional importance of this molecule within the tumor microenvironment.
Anti-metastatic effects by inducing apoptosis in tumor cells
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor-associated antigen GM2 (GM2).